8 September 2023
Vela Technologies plc
("Vela" or "the Company")
Update on Put Option for potential sale of Economic Interest in AZD1656
Further to the Company's announcements on 15 August 2023 and 7 September 2023, the Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, notes that Murphy Canyon Acquisition Corp. (NASDAQ: MURF) ("Murphy") announced yesterday that the special meeting of stockholders to approve, amongst other things, its initial business combination with Conduit Pharmaceuticals Limited has been postponed further and will now be held on 20 September 2023.
This meeting presents an opportunity for Murphy shareholders to provide their approval for the transaction.
A link to the previously filed notice of special meeting and final prospectus can be found here:
https://www.sec.gov/Archives/edgar/data/1896212/000149315223027856/form424b3.htm
On 20 April 2023, Vela announced that the Company entered into a put option agreement to give the Company the right, but not the obligation ("the Option"), to sell its economic interest in the commercialisation of the Covid-19 application of AZD1656 for a total consideration of £4.0 million. The Option was granted by Conduit Pharmaceuticals Limited ("Conduit") and its prospective parent company, Murphy, a Company listed on NASDAQ.
On 15 May 2023, Vela announced that Murphy had filed the Form S-4 Registration Statement and preliminary proxy statement with the SEC.
As previously announced, the Board of Vela is mindful that there can be no guarantee that Vela will be able to exercise the Option, since exercise is dependent on the successful completion of the merger between Conduit and Murphy and the combined entity being listed on the NASDAQ stock exchange.
The Company will release further announcements as and when appropriate.
For further information, please contact:
| Vela Technologies plc Brent Fitzpatrick, Non-Executive Chairman James Normand, Executive Director | Tel: +44 (0) 7410 886830
|
| Allenby Capital Limited (Nominated Adviser) | Tel: +44 (0) 20 3328 5656 |
| Nick Athanas / Piers Shimwell | |
| Peterhouse Capital Limited (Broker) | Tel: +44 (0) 20 7469 0930 |
| Lucy Williams / Duncan Vasey | |
| Novus Communications (PR and IR Adviser) | Tel: +44 (0) 20 7448 9839 |
| Alan Green / Jacqueline Briscoe | |
About Vela Technologies
Vela Technologies plc (AIM: VELA) is an investing company focused on early stage and pre-IPO long term disruptive technology investments. Vela's investee companies have either developed ways of utilising technology or are developing technology with a view to disrupting the businesses or sector in which they operate. Vela Technologies will also invest in already-listed companies where valuations offer additional opportunities.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
